Holen Sie sich die Stockscreener-App
1.19
0.83%
-0.01
Handel nachbörslich:
1.19
Schlusskurs vom Vortag:
$1.20
Offen:
$1.2
24-Stunden-Volumen:
64,464
Relative Volume:
0.40
Marktkapitalisierung:
$12.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.23M
KGV:
-0.9695
EPS:
-1.2274
Netto-Cashflow:
$-10.29M
1W Leistung:
-5.56%
1M Leistung:
-5.56%
6M Leistung:
-52.40%
1J Leistung:
-87.00%
1-Tages-Spanne:
$1.16
$1.21
1-Wochen-Bereich:
$1.13
$1.28
52-Wochen-Spanne:
$1.11
$13.85
Seastar Medical Holding Corp Stock (ICU) Company Profile
Firmenname
Seastar Medical Holding Corp
Sektor
Branche
Telefon
844-427-8100
Adresse
3513 BRIGHTON BLVD, DENVER
Vergleichen Sie ICU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
1.19 | 13.35M | 0 | -26.23M | -10.29M | -1.2274 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market - Yahoo Finance
SeaStar Medical secures second CMS trial coverage By Investing.com - Investing.com South Africa
SeaStar Medical (ICU) Secures CMS Coverage for Clinical Trial Ex - GuruFocus
SeaStar Medical secures second CMS trial coverage - Investing.com
SeaStar Medical Wins Elite CMS Coverage Status: Only 100 Trials Get This Medicare Advantage - Stock Titan
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients - citybuzz -
How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients - The Globe and Mail
SeaStar Medical (ICU) Announces Offering of Common Stock Shares | ICU Stock News - GuruFocus
Prediction: Rocket Lab USA Is Going Global - The Globe and Mail
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
SeaStar Medical Holding Corporation (NASDAQ:ICU) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: SeaStar Medical sees revenue surge in Q1 2025 - Investing.com
SeaStar Medical Holding Corp reports results for the quarter ended March 31Earnings Summary - TradingView
SeaStar Medical Holding Corp SEC 10-Q Report - TradingView
SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
SeaStar Medical (ICU) Hits Key Milestone in Clinical Trial | ICU Stock News - GuruFocus
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury - Yahoo Finance
SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 - Stock Titan
Medical Device Co. SeaStar Seeks Toss Of Shareholder Suit - Law360
SeaStar Medical To Report First Quarter Financial Results On May 14, 2025 - Barchart.com
SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately - Bluefield Daily Telegraph
Watch Live: SeaStar Medical CEO Reveals Latest Healthcare Innovation Insights on Benzinga - Stock Titan
SeaStar Medical Announces CEO Interview on Benzinga All - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
SeaStar Medical files to sell 3.5M shares of common stock for holders - MSN
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
ICU stock hits 52-week low at $1.2 amid market challenges - Investing.com
SeaStar Medical gains two new FDA breakthrough designations By Investing.com - Investing.com Australia
SeaStar Medical gains two new FDA breakthrough designations - Investing.com
Major FDA Win: SeaStar's Revolutionary Therapy Targets 45,000 Cardiac Surgery Patients - Stock Titan
Analyzing SeaStar Medical (NASDAQ:ICU) and Solventum (NYSE:SOLV) - Defense World
ICU stock hits 52-week low at $1.5 amid market challenges - Investing.com
SeaStar Medical reports USD 24.8 million loss in FY 2024 - Medical Buyer
Earnings call transcript: SeaStar Medical sees stock dip after Q4 2024 - Investing.com India
SeaStar Medical Holding Corp reports results for the quarter ended December 31Earnings Summary - TradingView
SeaStar Medical Achieves Key Milestones: FDA-Approved Therapy Generates Initial Sales - Stock Titan
SeaStar Medical Holding Corp expected to post a loss of 89 cents a shareEarnings Preview - TradingView
SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - The Manila Times
Healthcare Innovator SeaStar Medical Announces Key Financial Results Date: Critical Care Progress in Focus - Stock Titan
NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award - Quantisnow
Groundbreaking Pediatric Kidney Treatment Earns SeaStar Medical Prestigious NKF Award - Stock Titan
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Seastar Medical Holding Corp. to Contact the Firm Today! - ACCESS Newswire
Denver medical tech company fights to maintain Nasdaq listing - The Business Journals
SeaStar Medical secures Nasdaq listing extension By Investing.com - Investing.com Australia
SeaStar Medical secures Nasdaq listing extension - Investing.com India
SeaStar Medical’s director John Neuman acquires $153,227 in shares By Investing.com - Investing.com Canada
SeaStar Medical's director John Neuman acquires $153,227 in shares - Investing.com
SeaStar Medical’s director John Neuman acquires $153,227 in shares - Investing.com India
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SeaStar Medical secures $6 million in direct offering - MSN
SeaStar Medical (NASDAQ:ICU) versus OrthoPediatrics (NASDAQ:KIDS) Financial Review - Armenian Reporter
Finanzdaten der Seastar Medical Holding Corp-Aktie (ICU)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):